| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/13/1997 | WO1997005256A3 Mammalian pro-hormone convertase |
| 03/13/1997 | WO1997004007A3 Metal-containing ribonucleotide polypeptides |
| 03/13/1997 | WO1997003089A3 Method for the preparation of insulin by cleavage of a fusion protein and fusion proteins containing insulin a and b chains |
| 03/13/1997 | WO1997002277A3 Method for producing synthetic n-linked glycoconjugates |
| 03/13/1997 | WO1997000601A3 Polypeptides with interleukin-8 receptor binding |
| 03/13/1997 | WO1996040784A3 Method of solubilizing, purifying, and refolding protein |
| 03/13/1997 | WO1996040767A3 E6ap-binding proteins |
| 03/13/1997 | WO1996040041A3 Antibodies to fas antigen capable of inhibiting apoptosis |
| 03/13/1997 | CA2684425A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | CA2653566A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | CA2231788A1 Targeted nucleotide sequence delivery and integration system |
| 03/13/1997 | CA2231400A1 Vegf-related protein |
| 03/13/1997 | CA2231372A1 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 03/13/1997 | CA2231190A1 Cell-cycle checkpoint genes |
| 03/13/1997 | CA2230968A1 Method of treating insulin resistance |
| 03/13/1997 | CA2230927A1 Compounds and methods for diagnosis of tuberculosis |
| 03/13/1997 | CA2230861A1 Libraries of backbone-cyclized peptidomimetics |
| 03/13/1997 | CA2230858A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 03/13/1997 | CA2230795A1 Cyclin e variants and use thereof |
| 03/13/1997 | CA2230593A1 Rna polymerase transcription factor |
| 03/13/1997 | CA2228667A1 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 03/13/1997 | CA2228604A1 Isolation of microdomains of caveolae and gpi-anchored proteins |
| 03/13/1997 | CA2227301A1 Hcv binding protein |
| 03/12/1997 | EP0761815A2 Bacillus thuringiensis sporulation gene |
| 03/12/1997 | EP0761686A2 Anticoagulant factor Va derivatives |
| 03/12/1997 | EP0761685A2 Macrophage-derived inflammatory mediator (mip-1 alpha and mip-1 beta) |
| 03/12/1997 | EP0761684A2 Alanine substitution analogues of magainin peptides |
| 03/12/1997 | EP0761683A1 Protein or polypeptide, process for producing the same, and intermediate compound tehrefor |
| 03/12/1997 | EP0761681A2 Process for the preparation of substituted derivatives of N-ethylglycine |
| 03/12/1997 | EP0761233A2 Transkaryotic implantation |
| 03/12/1997 | EP0761230A2 Vaccine containing Bordetella pertussis outer membrane protein, and method of making such vaccine |
| 03/12/1997 | EP0761034A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch |
| 03/12/1997 | EP0760867A1 Compositions and methods relating to dna mismatch repair genes |
| 03/12/1997 | EP0760864A1 Dna encoding glutamate gated chloride channels |
| 03/12/1997 | EP0760858A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation |
| 03/12/1997 | EP0760857A1 Receptor for oncostatin m |
| 03/12/1997 | EP0760855A1 Hepatitis c virus asialoglycoproteins |
| 03/12/1997 | EP0760854A1 Lag1: a gene for increasing the longevity of eukaryotes |
| 03/12/1997 | EP0760853A1 Methods and associated reagents for detecting modulators of cytokine action |
| 03/12/1997 | EP0760852A1 Immunosuppressant target proteins |
| 03/12/1997 | EP0760851A1 Tumor necrosis factor receptor-associated factors |
| 03/12/1997 | EP0760850A1 P2x RECEPTORS (PURINOCEPTOR FAMILY) |
| 03/12/1997 | EP0760849A1 Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof |
| 03/12/1997 | EP0760823A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN |
| 03/12/1997 | EP0760685A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 03/12/1997 | EP0760682A1 Gene transfer-mediated angiogenesis therapy |
| 03/12/1997 | EP0760681A1 Modification of clostridial toxins for use as transport proteins |
| 03/12/1997 | EP0760675A1 Compositions comprising dna damaging agents and p53 |
| 03/12/1997 | EP0760674A1 Inhibition of infection of mammalian cells by respiratory syncytial virus |
| 03/12/1997 | EP0760673A1 INHIBITION OF ATTACHMENT OF $i(H. INFLUENZAE) TO HUMAN CELLS |
| 03/12/1997 | EP0760671A1 Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
| 03/12/1997 | EP0760652A1 Compositions for neutralization of lipopolysaccharides |
| 03/12/1997 | EP0760602A1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
| 03/12/1997 | EP0644774A4 Improved production of reproductive hormones. |
| 03/12/1997 | EP0627001A4 Mammalian sos - a regulator/effector of tyrosine kinase signalling. |
| 03/12/1997 | EP0538283B1 Synthetic peptides and mixtures thereof for detecting hiv antibodies |
| 03/12/1997 | EP0489048B1 Inhibition of tumor growth by blockade of the protein c system |
| 03/12/1997 | EP0378671B1 Insulinomimetic and insulin receptor binding site peptides |
| 03/12/1997 | EP0367767B1 Bacillus thuringiensis p-2 toxin gene, protein and related insecticide compositions |
| 03/12/1997 | CN1145097A Human DNA mismatch repair proteins |
| 03/12/1997 | CN1145077A Immuno-stimulatory monoclonal antibodies |
| 03/12/1997 | CN1145076A Prostaglandin I2 receptor |
| 03/12/1997 | CN1145033A Human therapeutic uses of BPI protein products |
| 03/12/1997 | CN1145032A Monoclonal anbibodies which bind to tumor rejection antigen precursor MAGE-1, recombinant MAGE-1, and MAGE-1 derived immunogenic peptides |
| 03/11/1997 | US5610286 DNA's encoding natural killer cell enhancing factor |
| 03/11/1997 | US5610285 Purification of α-1 proteinase inhibitor using novel chromatographic separation conditions |
| 03/11/1997 | US5610284 Method of purification of human BCDF |
| 03/11/1997 | US5610283 Opiate derivatives and protein and polypeptide opiate derivative conjugates and labels |
| 03/11/1997 | US5610282 cDNA encoding a rat D1 dopamine receptor linked to adenylyl cyclase activation and expression of the receptor protein in plasmid-transfected cell lines |
| 03/11/1997 | US5610281 Monoclonal antibody which specifically binds to human e-cadherin |
| 03/11/1997 | US5610279 Human TNF receptor |
| 03/11/1997 | US5610278 Process for producing a coagulation active complex of factor VIII fragments |
| 03/11/1997 | US5610277 Alcohol-free wet extraction of gluten dough into gliadin and glutenin |
| 03/11/1997 | US5610276 Determination whether a cell is cancerous |
| 03/11/1997 | US5610272 Solid phase process for synthesizing thymosin α1 |
| 03/11/1997 | US5610271 Kappa receptor selective opioid peptides |
| 03/11/1997 | US5610148 Macroscopically oriented cell adhesion protein for wound treatment |
| 03/11/1997 | US5610141 Cell division stimulant |
| 03/11/1997 | US5610137 Transgenic, cross-linked hemoglobin |
| 03/11/1997 | US5610067 Method of preparing plasmid having both expressing ability of retroviral gene and processing ability after translation, and resultant plasmid and expression products |
| 03/11/1997 | US5610066 Nucleic acid modifying proteins from Pyrococcus furiosus |
| 03/11/1997 | US5610060 Isolated Helicobacter hepaticus |
| 03/11/1997 | US5610059 Etiological agent for porcine enteritis |
| 03/11/1997 | US5610058 Cytotrophoblast antigen and monoclonal antibodies which specifically bind cytotrophoblast cells |
| 03/11/1997 | US5610057 Monoclonal antibody specific for IgA receptor |
| 03/11/1997 | US5610054 Enzymatic RNA molecule targeted against Hepatitis C virus |
| 03/11/1997 | US5610053 DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells |
| 03/11/1997 | US5610050 Methods of preventing viral replication |
| 03/11/1997 | US5610048 Xylanase, DNA sequences, coding for the xylanases and methods of use thereof |
| 03/11/1997 | US5610044 Microorganisms with mannopine catabolizing ability |
| 03/11/1997 | US5610036 Mutant AOX2 promoter, microorganism carrying same, method of preparation thereof and production of heterologous protein using such microorganism |
| 03/11/1997 | US5610034 Immunoglobulin production by trichoderma |
| 03/11/1997 | US5610033 Method of producing proteins with FVIII activity and/or FVIII derivatives |
| 03/11/1997 | US5610032 AMPA-binding human GluR1 receptors |
| 03/11/1997 | US5610031 B1k chain of laminin and methods of use |
| 03/11/1997 | US5610023 Method of purification of clostridium difficile toxin A and production of mono-specific antibodies |
| 03/11/1997 | US5610019 Methods of detecting phospholipid transfer activity and kits therefor |
| 03/11/1997 | US5610018 Mitogenic signal transduction pathway |
| 03/11/1997 | US5610015 System to detect protein-RNA interactions |
| 03/11/1997 | US5610013 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |